Soc. Generale Call 194.42 ILMN 20.../ DE000SQ49788 /
07/11/2024 20:20:16 | Var.+0.005 | Denaro21:09:29 | Lettera21:09:29 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
0.052EUR | +10.64% | 0.056 Quantità in denaro: 80,000 |
0.066 Quantità in lettera: 80,000 |
Illumina Inc | 194.42 USD | 20/12/2024 | Call |
GlobeNewswire
01/08
Outpace Bio Announces $144M Oversubscribed Series B Financing to Advance AI-powered Cell Therapies i...
GlobeNewswire
29/07
Palisade Bio Successfully Completes Microbiome Study Confirming Bacterial Enzymes for Local Bioactiv...
GlobeNewswire
23/07
Novogene to Power Cancer, Rare Disease, and Environmental Research with PacBio Sequencing
GlobeNewswire
09/07
Paragon Genomics Partners with Biosecure ID to Expand Access to CleanPlex® Technology in the UK and ...
GlobeNewswire
20/06
Bionano Announces Software Marketing Agreement with Revvity for Newborn Sequencing Research
GlobeNewswire
03/06
AMD Extends AI and High-Performance Leadership in Data Center and PCs with New AMD Instinct, Ryzen a...
GlobeNewswire
29/05
QIAGEN launches new library preparation kit, facilitating multiomic studies and advancing precision ...
GlobeNewswire
09/05
Attovia Therapeutics Raises $105 Million Oversubscribed Series B Financing Led by Goldman Sachs Alte...
GlobeNewswire
04/03
Baylor Genetics to Share Scientific and Clinical Insights on AI, Precision Diagnostics, Carrier Scre...
GlobeNewswire
27/02
ILLUMINA ALERT: Bragar Eagel & Squire, P.C. is Investigating Illumina, Inc. on Behalf of Long-Term S...
GlobeNewswire
09/01
DEADLINE ALERT for PAYC, ILMN, and JRVR: The Law Offices of Frank R. Cruz Reminds Investors of Class...
GlobeNewswire
09/01
ILMN DEADLINE TODAY: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Illumina, Inc. Investors with Lo...
GlobeNewswire
08/01
SHAREHOLDER ALERT: Levi & Korsinsky Notifies Illumina, Inc. (ILMN) Investors of a Class Action Lawsu...